ストックスクリーナーアプリを入手
21.59
1.31%
0.2276
前日終値:
$21.36
開ける：
$21.72
24時間の取引高:
3.42M
Relative Volume:
0.10
時価総額：
$4.93B
収益：
$2.35B
当期純損益:
$128.37M
株価収益率:
41.35
EPS:
0.5221
ネットキャッシュフロー:
$57.42M
1週間 パフォーマンス:
+11.60%
1か月 パフォーマンス:
-12.64%
6か月 パフォーマンス:
-65.52%
1年 パフォーマンス:
-26.55%
1日の値動き範囲:
$21.28
$21.83
1週間の範囲:
$18.96
$21.96
52週間の値動き範囲:
$13.74
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Compare HIMS vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
21.63 | 4.87B | 2.35B | 128.37M | 57.42M | 0.5221 |
TAK
Takeda Pharmaceutical Co Adr
|
17.89 | 56.39B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.42 | 50.93B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.695 | 43.19B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.33 | 36.99B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.13 | 25.36B | 3.18B | 1.33B | 1.04B | 27.90 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2026-03-10 | アップグレード | Citigroup | Sell → Neutral |
| 2026-03-09 | アップグレード | Needham | Hold → Buy |
| 2026-02-24 | ダウングレード | BTIG Research | Buy → Neutral |
| 2026-01-12 | 開始されました | Evercore ISI | In-line |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Hims & Hers: Bargain EBITDA Multiples As GLP-1 Drama Passes - Seeking Alpha
Hims Didn't Protect Customer Data From Hackers, Suit Says - Law360
Hims & Hers Powers Patient-Provider Connectivity via Digital Platforms - The Globe and Mail
Modest gains for Hims & Hers Health stock as $21.38 resistance remains in focus - Traders Union
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know - Yahoo Finance
Hims & Hers Health Inc (HIMS) Shares Surge 8.8% -- What GF Score of 76 Tells Investors - GuruFocus
Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026 - The Joplin Globe
Hims & Hers schedules May 11 earnings release, 5 p.m. ET call - Stock Titan
Hims & Hers Health (HIMS) jumps 9.8% as GLP-1 partnership momentum returns to focus - Quiver Quantitative
Hims & Hers Health stock rises as sellers remain in control of the short-term trend - Traders Union
Okta breach chain hits Hims & Hers in wider ShinyHunters attack spree - Cybernews
Why Hims & Hers Health, Inc. (HIMS) Surged On Friday - MSN
Hims & Hers Health, Inc. Class A Trade Ideas — LS:A2QMYY - TradingView
A Look At Hims & Hers (HIMS) Valuation After GLP 1 Crackdown And Wegovy Pivot - Yahoo Finance
Hims And Hers Confronts Amazon Threat While Advancing AI Weight Loss Plan - Yahoo Finance
Hims & Hers (NYSE: HIMS) CEO makes 845,866-share bona fide gift - Stock Titan
HIMS Stock Jumps Premarket: CEO Targets 100K Monthly Wegovy Push After Novo Nordisk Truce - Stocktwits
Hims Breach Exposes the Most Sensitive Kinds of PHI - Dark Reading
Hims & Hers Health stock price forecast: $21.38 resistance in focus as HIMS drops 1.87% - Traders Union
Why Is HIMS Stock Down 40%? - Trefis
Did Hims & Hers Just Become an AI Company? - The Globe and Mail
Liquidity Mapping Around (HIMS) Price Events - Stock Traders Daily
Investor relations - HIMS Investor Relations
2 Profitable Stocks with Exciting Potential and 1 We Ignore - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Encourages Hims & Hers Health - The National Law Review
Hims & Hers (HIMS) Stock Plummets 39% Amid GLP-1 Strategy Shift and Margin Pressure - MEXC
Why Is HIMS Stock Slipping Premarket Today? - Stocktwits
Hims & Hers (HIMS) Stock Down 39% as GLP-1 Brand Transition Squeezes Margins - CoinCentral
Hims & Hers’ Shift to Branded Obesity Drugs Pressures Stock — Will the Bet Pay Off? - TipRanks
Hims & Hers Health (HIMS) Is Down 6.1% After Expanding GLP-1 Access With Novo Nordisk Collaboration - Sahm
Hims & Hers Health stock rises as FDA-approved Wegovy and Ozempic come back to market - Traders Union
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Hims & Hers Health Is No Longer What The Market Thinks (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health, Inc. Jumps 5.5% Amid Sector-Wide Selling - AlphaStreet
BofA cuts Hims and Hers stock price target on EBITDA concerns - Investing.com
Hims & Hers Health (HIMS) Valuation Check As Novo Nordisk GLP 1 Partnership Reopens Growth Path - Sahm
Hims & Hers Health, Inc. (HIMS) Shares Decline as Broader Market Advances: Important Details - Bitget
Okupe, Hims & Hers health CFO, sells $79k in shares - Investing.com India
Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Hims & Hers Faces Legal Scrutiny as Novo Nordisk Partnership Ends - timothysykes.com
Hims & Hers Faces Legal Scrutiny After Novo Nordisk Ends Partnership - timothysykes.com
Hackers access names, contact information of some Hims customers - Modern Healthcare
Hims & Hers Health stock falls as insider files to sell shares - Investing.com
Hims & Hers Health (HIMS) Is Up 8.3% After Expanding Novo Nordisk GLP-1 Partnership And Launching New Weight-Loss MembershipHas The Bull Case Changed? - Yahoo Finance
3 Sectors to Buy While They’re Down and 1 to Walk Away From - Investing.com
Hims & Hers Health and Fortune Brands Innovation have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research
3 Sectors to Buy While They're Down and 1 to Walk Away From - MarketBeat
Hims & Hers Health, Inc. (82W.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Hims & Hers Health, Inc. (HIMS) stock price, news, quote and history - Yahoo Finance UK
Hims & Hers (HIMS) Taps Into $200-Billion Weight Loss Market, Soars 6% - insidermonkey.com
Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
1.14%
0.25%
大文字化:
|
ボリューム (24 時間):